article thumbnail

The host immune response in COVID-19 and beyond

pharmaphorum

MeMed CEO Dr. Eran Eden explores the relationship between the host immune response and SARS-CoV-2 infection and how technology could help personalise treatment strategies. One of these involves listening to what the body’s own immune system can tell us. This is made possible using ‘Advanced Host Immune Response Technologies’.

article thumbnail

Health Innovators: PureTech Health’s Daphne Zohar

pharmaphorum

They discuss the publicly-listed biotech’s pipeline projects and focus on the BIG (brain-immune-gut) axis as well as PureTech’s interest in digital therapeutics. Prior to this, he founded pharmaphorum in 2009, which was acquired by Healthware Group in June 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How global healthcare partners and Indian pharma companies are contributing to affordable medicines

Express Pharma

Indian pharmaceutical companies play a crucial role in fulfilling global demand for critical vaccines, including those endorsed by the World Health Organization (WHO) for diseases (like Tetanus, Pertussis, Diphtheria, and Bacillus Calmette-Guerin), highlighting India’s indispensable contribution to global immunization efforts.

Vaccines 104
article thumbnail

Merck Reports the US FDA Acceptance of sBLA for Keytruda (pembrolizumab) to Treat Advanced or Unresectable Biliary Tract Cancer

PharmaShots

OS rate (52% & 24.9%

article thumbnail

Low Dose Naltrexone and Hashimoto’s

The Thyroid Pharmacist

However, low doses of this medication (hence, low dose naltrexone or LDN), have been found to modulate the immune system and have shown promise in improving cases of autoimmune disease. These include Crohn’s, MS, and Hashimoto’s, as well as other immune system-related conditions such as cancer and HIV/AIDS. Doses of 1.5-4.5

article thumbnail

Things to Know About the INBDE Dental Board Exam

Board Vitals - Pharmacist

Cellular and molecular bases of immune and non-immune host defense mechanisms: 9.0% These areas of fundamental knowledge are further divided among the following INBDE subject areas : Molecular, biochemical, cellular, and systems-level development, structure, and function: 12.2% Pharmacology: 10.6% How much does the INBDE cost ?

article thumbnail

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

PharmaShots

Company: AstraZeneca First Approval Date: Jul 31, 2009 Generic Name: Saxagliptin Patent Expiration: Jan 2023 2022 Sales: $257M Indication: Type 2 Diabetes Mellitus Onglyza is a member of the dipeptidyl peptidase-4 inhibitor class of oral hypoglycemics used combined with diet and exercise for managing type 2 diabetes.